Target RWE Highlights GLP-1 Receptor Agonists in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease at The Liver Meeting 2024
Target RWE, a leader in real-world evidence solutions in liver disease, presented important research on the use of ...
World Socialist Web Site8h
Will Medicare and Medicaid coverage for anti-obesity drugs survive RFK Jr.?
poll finding that one in eight adult Americans has taken a Glucagon-like peptide-1 (GLP-1), the technical name for ...
Health on MSN1h
How Ozempic Affects Fertility, Birth Control, and Pregnancy
Medically reviewed by Peter Weiss, MD Ozempic is the brand name of a medication called semaglutide, a glucagon-like peptide-1 ...
Medscape2h
Is Bariatric Surgery at Risk of Becoming Obsolete?
While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...
Medscape6h
ADA Advises Against Using Compounded GLP-1 RA Medications
In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...
GLP-1s: Employers need to understand their impact
For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.
Why do people on Ozempic and other obesity drugs lose interest in alcohol
Weight loss medications like Ozempic, Wegovy, and Mounjaro are not only effective in curbing appetite but also in reducing ...
Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?
We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...
2 Disruptive Growth Stocks With Room to Run
The investment landscape has transformed since the presidential election, with small-cap stocks gaining momentum. The Russell ...
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...
MM&M17h
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid
Ozempic and other glucagon-like peptide-1 (GPL-1) agonist medications accounted for 10% of the state employee health plan’s ...
Pharmabiz1h
BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide
BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...